Non Invasive Liposuction
Non-Invasive Liposuction
The UltraShape procedure for men and women is the first clinically proven non-invasive body contouring system to disrupt fat cells safely and effectively.
UltraShape uses proprietary focused ultrasound technology which targets adipose tissue only, leaving critical surrounding structures intact. The lysed fat cells are safely cleared away by the body's natural physiological metabolic pathways.
UltraShape delivers measurable and durable results: Multiple treatments are recommended for incremental fat thickness and circumference reduction and overall enhanced results. Average reduction in circumference, after three treatments, of 3.95 ± 1.99 cm (Moreno-Moraga et al, LSM, April 2007).
The vast majority of patients report no pain or discomfort during or following treatment. The treatment requires no anesthesia or sedation. UltraShape is a convenient, “walk-in, walk-out” treatment carried out in an office-based environment. The treatment can be performed in as little as an hour in a certified physician’s office and after treatment, patients can immediately resume their normal daily activities and there is no need for maintenance treatments. UltraShape’s technology uses focused therapeutic ultrasound energy which, when applied to the subcutaneous fat layer, causes a mechanical (non-thermal) effect. This mechanical effect results in selective tissue disruption: only adipose tissue within the targeted area are disrupted, leaving neighbouring critical structures intact.
The UltraShape treatment is guided by a patented tracking and guidance system which ensures complete and uniform treatment of the marked area to deliver smooth body contouring results: it prevents treatment beyond the pre-marked zone, recording and synchronising the body’s position in real-time to allow for breathing and movement.
UltraShape disrupts the fat
cell membranes, causing the release of triglycerides (TG) from the cells. Triglycerides are then broken down into free
fatty acids and glycerol by an enzyme called Lipase. The free fatty acids and the glycerol are
transported by the natural mechanisms of the body to the liver. Free fatty acids, being insoluble in water,
bind to albumin and are slowly transported to the liver, while the glycerol,
which is soluble in water, is transported to the liver by the blood stream. The
TG or its derivatives are therefore naturally processed by known metabolic
pathways. The liver makes no distinction between fat originating from the
disrupted fat cells (adipocytes) and fat derived from a consumed meal.
UltraShape’s published
multi-center controlled clinical study and other independent clinical trials
have shown that released triglycerides do not accumulate to any clinically
significant extent in the blood or liver. The
clearance of the cell debris occurs through a
physiological healing process over the first 3-4 weeks. Immediately following
completion of treatment, the patient can simply go back to his or her normal
routine but will be advised to exercise regularly and maintain a healthy diet.
Before and After Images


In the News
Please click the links below to view news coverage of Ultrashape
ABC News Ultrashape Special
CTV Ultrashape Special
White Papers
Please download the white papers for Ultrashape for an in-depth look into successful clinical research.
Brown Clinical Paper
Otto Clinical Paper
